Tumor downstaging in muscle invasive bladder cancer with neoadjuvant systemic therapy—does it lead to prolonged survival?

Detalles Bibliográficos
Autores principales: Tachibana, Isamu, Kaimakliotis, Hristos Z.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Editorial Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7215006/
https://www.ncbi.nlm.nih.gov/pubmed/32420193
http://dx.doi.org/10.21037/tau.2019.12.28
_version_ 1783532092061122560
author Tachibana, Isamu
Kaimakliotis, Hristos Z.
author_facet Tachibana, Isamu
Kaimakliotis, Hristos Z.
author_sort Tachibana, Isamu
collection PubMed
description
format Online
Article
Text
id pubmed-7215006
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher AME Publishing Company
record_format MEDLINE/PubMed
spelling pubmed-72150062020-05-15 Tumor downstaging in muscle invasive bladder cancer with neoadjuvant systemic therapy—does it lead to prolonged survival? Tachibana, Isamu Kaimakliotis, Hristos Z. Transl Androl Urol Editorial Commentary AME Publishing Company 2020-04 /pmc/articles/PMC7215006/ /pubmed/32420193 http://dx.doi.org/10.21037/tau.2019.12.28 Text en 2020 Translational Andrology and Urology. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) .
spellingShingle Editorial Commentary
Tachibana, Isamu
Kaimakliotis, Hristos Z.
Tumor downstaging in muscle invasive bladder cancer with neoadjuvant systemic therapy—does it lead to prolonged survival?
title Tumor downstaging in muscle invasive bladder cancer with neoadjuvant systemic therapy—does it lead to prolonged survival?
title_full Tumor downstaging in muscle invasive bladder cancer with neoadjuvant systemic therapy—does it lead to prolonged survival?
title_fullStr Tumor downstaging in muscle invasive bladder cancer with neoadjuvant systemic therapy—does it lead to prolonged survival?
title_full_unstemmed Tumor downstaging in muscle invasive bladder cancer with neoadjuvant systemic therapy—does it lead to prolonged survival?
title_short Tumor downstaging in muscle invasive bladder cancer with neoadjuvant systemic therapy—does it lead to prolonged survival?
title_sort tumor downstaging in muscle invasive bladder cancer with neoadjuvant systemic therapy—does it lead to prolonged survival?
topic Editorial Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7215006/
https://www.ncbi.nlm.nih.gov/pubmed/32420193
http://dx.doi.org/10.21037/tau.2019.12.28
work_keys_str_mv AT tachibanaisamu tumordownstaginginmuscleinvasivebladdercancerwithneoadjuvantsystemictherapydoesitleadtoprolongedsurvival
AT kaimakliotishristosz tumordownstaginginmuscleinvasivebladdercancerwithneoadjuvantsystemictherapydoesitleadtoprolongedsurvival

Ejemplares similares